RxDoctor Payments Data

Mylhan Myers, DO

Family Medicine · Rolla, MONPI 1639699747

Payments from drug & device makers

$1,068in general payments, 2019–2025

Across 57 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$230
  • AbbVie$194
  • Medtronic$78
  • Otsuka America Pharmaceutical, Inc.$74
  • Novartis$60
  • AstraZeneca$60
  • plus $372 from 15 others

What the payments were for

  • Food & beverage$1,068100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,068 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$8,106
Medicare patients
32
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$43,597
JardianceEmpagliflozin49$42,951
FarxigaDapagliflozin Propanediol41$39,692
EliquisApixaban43$29,460
XareltoRivaroxaban21$12,878
RybelsusSemaglutide13$12,395
Aimovig AutoinjectorErenumab-Aooe11$8,361
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,792
SymbicortBudesonide/Formoterol Fumarate11$2,555
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$1,943
Metoprolol Succinate57$811
Gabapentin37$595
Atorvastatin Calcium105$441
Rosuvastatin Calcium80$415
Omeprazole38$413

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$230$55,99258 claims
AstraZenecaFarxiga, Symbicort$60$42,24752 claims
PfizerEliquis$31$29,46043 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →